id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-2273-0003,FDA,FDA-2019-E-2273,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T15:49:15Z,,0,0,0900006483d31769
FDA-2019-E-2273-0001,FDA,FDA-2019-E-2273,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T16:58:14Z,,0,0,0900006483c4e650
FDA-2019-E-2273-0002,FDA,FDA-2019-E-2273,Patent Extension Application from Millen White Zelano & Branigan PC (on behalf of AiCuris Anti-Infective Cures GmbH),Other,Application,2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T17:03:49Z,,0,0,0900006483c4e3d8